Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (1 active)

Company-led only

4 records in Main database · 2 strong · 4 status checked

Compare	Program	Company / Sponsor	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	CIL001 (Paliroden) by Cilcare	Cilcare SAS	Therapeutic	-	Small Molecule	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultDiabetes+2	Hearing LossSensorineural Hearing Loss+2
Add	NS101 by Neuracle Science	Neuracle Science Co., Ltd.	Therapeutic	-	Biologic	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	OTO-413 by Otonomy	Otonomy	Therapeutic	-	Biologic	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	95%	AdultNoise-Induced	Hearing LossSensorineural Hearing Loss+2
Add	PIPE-505 by Pipeline Therapeutics	Contineum Therapeutics	Therapeutic	-	Small Molecule	Phase 1/2	Completed	Details checkedStatus confirmedHistorical/discontinued	trial · Priority 2	86%	Adult	Hearing LossSensorineural Hearing Loss+2